+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 5Days - 5Years
All Genders
ID07888868

Evaluation of Newborn Screening Implementation for Spinal Muscular Atrophy Across UK NHS Laboratories

Led by University of Oxford · Updated on 2026-10-22

750000

Participants Needed

3

Research Sites

21 weeks

Total Duration

AI-Summary

What This Trial Is About

Spinal Muscular Atrophy SMA is a condition causing progressive muscle weakness, with the most severe form affecting very young babies and being life-threatening if untreated. This study evaluates the introduction of newborn screening NBS for SMA across seven NHS laboratories in the UK, aiming to determine if such screening improves early diagnosis, treatment timing, and long-term outcomes. The study also assesses the acceptability of screening for different groups and its cost-effectiveness for the NHS. Screening for SMA will be gradually implemented between autumn 2026 and autumn 2027, covering about 400,000 babies born annually in the study areas. The study has two phases Phase 1 focuses on the delivery and accuracy of SMA screening and parental acceptance, while Phase 2 investigates the longer-term health and quality of life outcomes for children diagnosed by NBS or standard care. The study collects information from parents, healthcare providers, and a national clinical network to evaluate these aspects. Participants include newborns born between October 2026 and September 2030 who are eligible for SMA screening, as well as children diagnosed with SMA through different routes within specified birth periods. The study involves consent at the routine heel-prick blood test, data collection on developmental milestones and health, and economic analysis of screening costs versus benefits. The primary outcome report is expected in January 2031, with multiple secondary outcomes reported between 2028 and 2031.

CONDITIONS

Brief Title

Service Evaluation for Newborn Screening for Spinal Muscular Atrophy

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here